clinical evaluation of Parangichakkai chooranam (internal) and Karappan ennai(external)in the treatment of Balakarappan(Atopic dermatitis) in children.

Clinical Evaluation of PARANGICHAKKAI CHOORANAM(Internal) and KARAPPAN ENNAI(External)in the treatment of BALAKARAPPAN (Atopic dermatitis) in children. - Atopic dermatitis

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/05/019123

Enrollment

Registered

2019-05-14

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

Intervention1: parangichakkai chooranam(internal) and karappan ennai(external): parangichakkai chooranam,5to6 years-1.3gm,7to12years-2gm will be administrated orally,afterfood twice a day and karappan

Eligibility

Inclusion criteria

Inclusion criteria: children of both sexes in the age group of 5 to 12 years with symptoms of: 1.Erythema 2.Edema 3.Oozing 4.Itching 5.Crusting and Scaling 6.Lichenified plaque

Exclusion criteria

Exclusion criteria: 1.Scabies 2.photodermatitis 3.Fungal and parasitic skin infection 4.Psoriasis 5.Any other serious illness

Design outcomes

Primary

Measure	Time frame
to evaluate the efficacy of Parangichakkai chooranam (Internal) and Karappan ennai(external)in the treatment of Balakarappan(Atopic dermatitis) using EASI ScoreTimepoint: 1 to 45 days	—

Secondary

Measure	Time frame
to standardize the physico chemical properties of the trial drugs. To study the effect of trial drug in reducing the frequency of incidence ofBalakarappanTimepoint: 3 months	—

Countries

India

Contacts

Public ContactDrMMeenakshi sundaram

NationaL Institute of siddha

mmssiddha@gmail.com9444214582

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026